References
- 1Tsao, CW, Aday AW, Almarzooq ZI, Alonso A, Beaton AZ, Bittencourt MS, et al. Heart disease and stroke statistics-2022 update: A report from the American Heart Association. Circulation. 2022 Feb 22; 145(8): e153–e639. Epub 2022 Jan 26. Erratum in: Circulation. 2022 Sep 6. 146(10): e141. PMID: 35078371. DOI: 10.1161/CIR.0000000000001052
- 2GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020 Oct 17; 396(10258): 1204–1222. Erratum in: Lancet. 2020 Nov 14. 396(10262): 1562. PMID: 33069326; PMCID: PMC7567026. DOI: 10.1016/S0140-6736(20)30925-9
- 3Ezzati M, Obermeyer Z, Tzoulaki I, Mayosi BM, Elliott P, Leon DA. Contributions of risk factors and medical care to cardiovascular mortality trends. Nature Reviews Cardiology. 2015 Sep; 12(9): 508–30. Epub 2015 Jun 16. PMID: 26076950; PMCID: PMC4945698. DOI: 10.1038/nrcardio.2015.82
- 4Yousefi PD, Suderman M, Langdon R, Whitehurst O, Davey Smith G, Relton CL. DNA methylation-based predictors of health: Applications and statistical considerations. Nat Rev Genet. 2022 Jun; 23(6): 369–383. Epub 2022 Mar 18. PMID: 35304597. DOI: 10.1038/s41576-022-00465-w
- 5Westerman K, Sebastiani P, Jacques P, Liu S, DeMeo D, Ordovás JM. DNA methylation modules associate with incident cardiovascular disease and cumulative risk factor exposure. Clin Epigenetics. 2019 Oct 15. 11(1): 142. PMID: 31615550; PMCID: PMC6792327. DOI: 10.1186/s13148-019-0705-2
- 6Jones PA, Takai D. The role of DNA methylation in mammalian epigenetics. Science. 2001 Aug 10; 293(5532): 1068–70. PMID: 11498573. DOI: 10.1126/science.1063852
- 7Wolffe AP, Matzke MA. Epigenetics: Regulation through repression. Science. 1999 Oct 15; 286(5439): 481–6. PMID: 10521337. DOI: 10.1126/science.286.5439.481
- 8Schiattarella GG, Madonna R, Van Linthout S, Thum T, Schulz R, Ferdinandy P, Perrino C. Epigenetic modulation of vascular diseases: Assessing the evidence and exploring the opportunities. Vascul Pharmacol. 2018 Mar 14; S1537–1891(17): 30468–8. Epub ahead of print. PMID: 29548901. DOI: 10.1016/j.vph.2018.02.009
- 9Fernández-Sanlés A, Sayols-Baixeras S, Subirana I, Degano IR, Elosua R. Association between DNA methylation and coronary heart disease or other atherosclerotic events: A systematic review. Atherosclerosis. 2017 Aug; 263: 325–333. Epub 2017 May 18. PMID: 28577936. DOI: 10.1016/j.atherosclerosis.2017.05.022
- 10Domingo-Relloso A, Makhani K, Riffo-Campos AL, Tellez-Plaza M, Klein KO, Subedi P, et al. Arsenic exposure, blood DNA methylation, and cardiovascular disease. Circ Res. 2022 Jul 8; 131(2): e51–e69. Epub 2022 Jun 6. PMID: 35658476. PMCID: PMC10203287. DOI: 10.1161/CIRCRESAHA.122.320991
- 11Mao X, Huang C, Wang Y, Mao S, Li Z, Zou W, Liao Z. Association between dietary habits and pancreatitis among individuals of European ancestry: A two-sample Mendelian randomization study. Nutrients. 2023 Feb 24. 15(5): 1153. PMID: 36904153; PMCID: PMC10004739. DOI: 10.3390/nu15051153
- 12Budu-Aggrey A, Paternoster L. Research techniques made simple: Using genetic variants for randomization. J Invest Dermatol. 2019 Jul; 139(7): 1416–1421.e1. PMID: 31230636. DOI: 10.1016/j.jid.2019.03.1138
- 13Burgess S, Scott RA, Timpson NJ, Davey Smith G, Thompson SG, EPIC- InterAct Consortium. Using published data in Mendelian randomization: A blueprint for efficient identification of causal risk factors. Eur J Epidemiol. 2015 Jul; 30(7): 543–52. Epub 2015 Mar 15. PMID: 25773750; PMCID: PMC4516908. DOI: 10.1007/s10654-015-0011-z
- 14Dimou NL, Tsilidis KK. A primer in Mendelian randomization methodology with a focus on utilizing published summary association data. Methods Mol Biol. 2018; 1793: 211–230. PMID: 29876899. DOI: 10.1007/978-1-4939-7868-7_13
- 15Hingorani A, Humphries S. Nature’s randomised trials. Lancet. 2005 Dec 3; 366(9501): 1906–8. PMID: 16325682. DOI: 10.1016/S0140-6736(05)67767-7
- 16Skrivankova VW, Richmond RC, Woolf BAR, Yarmolinsky J, Davies NM, Swanson SA, et al. Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: The STROBE-MR statement. JAMA. 2021 Oct 26. 326(16): 1614–1621. PMID: 34698778. DOI: 10.1001/jama.2021.18236
- 17McCartney DL, Min JL, Richmond RC, Lu AT, Sobczyk MK, Davies G, et al. Genome-wide association studies identify 137 genetic loci for DNA methylation biomarkers of aging. Genome Biol. 2021 Jun 29; 22(1): 194. PMID: 34187551. PMCID: PMC8243879. DOI: 10.1186/s13059-021-02398-9
- 18Warnecke RB, Oh A, Breen N, Gehlert S, Paskett E, Tucker KL, et al. Approaching health disparities from a population perspective: The National Institutes of Health Centers for Population Health and Health Disparities. Am J Public Health. 2008 Sep; 98(9): 1608–15. Epub 2008 Jul 16. PMID: 18633099. PMCID: PMC2509592. DOI: 10.2105/AJPH.2006.102525
- 19Giurgescu C, Nowak AL, Gillespie S, Nolan TS, Anderson CM, Ford JL, et al. Neighborhood environment and DNA methylation: Implications for cardiovascular disease risk. J Urban Health. 2019 Mar; 96(Suppl 1): 23–34. PMID: 30635842. PMCID: PMC6430282. DOI: 10.1007/s11524-018-00341-1
- 20Westerman KE, Ordovás JM. DNA methylation and incident cardiovascular disease. Curr Opin Clin Nutr Metab Care. 2020 Jul; 23(4): 236–240. PMID: 32487875. DOI: 10.1097/MCO.0000000000000659
- 21Palou-Márquez G, Subirana I, Nonell L, Fernández-Sanlés A, Elosua R. DNA methylation and gene expression integration in cardiovascular disease. Clin Epigenetics. 2021 Apr 9. 13(1): 75. PMID: 33836805; PMCID: PMC8034168. DOI: 10.1186/s13148-021-01064-y
- 22Navas-Acien A, Domingo-Relloso A, Subedi P, Riffo-Campos AL, Xia R, Gomez L, et al. Blood DNA methylation and incident coronary heart disease: Evidence from the Strong Heart Study. JAMA Cardiol. 2021 Nov 1; 6(11): 1237–1246. PMID: 34347013. PMCID: PMC8340006. DOI: 10.1001/jamacardio.2021.2704
- 23Westerman KE, Ordovás JM. DNA methylation and incident cardiovascular disease. Curr Opin Clin Nutr Metab Care. 2020 Jul; 23(4): 236–240. PMID: 32487875. DOI: 10.1097/MCO.0000000000000659
- 24Wang Y, Eliot MN, Wellenius GA. Short-term changes in ambient particulate matter and risk of stroke: A systematic review and meta-analysis. J Am Heart Assoc. 2014 Aug 7. 3(4):
e000983 . PMID: 25103204; PMCID: PMC4310387. DOI: 10.1161/JAHA.114.000983 - 25Omar M, Alexiou M, Rekhi UR, Lehmann K, Bhardwaj A, Delyea C, et al. DNA methylation changes underlie the long-term association between periodontitis and atherosclerotic cardiovascular disease. Front Cardiovasc Med. 2023 Apr 21; 10:
1164499 . PMID: 37153468. PMCID: PMC10160482. DOI: 10.3389/fcvm.2023.1164499 - 26Cash HL, McGarvey ST, Houseman EA, Marsit CJ, Hawley NL, Lambert-Messerlian GM, et al. Cardiovascular disease risk factors and DNA methylation at the LINE-1 repeat region in peripheral blood from Samoan Islanders. Epigenetics. 2011 Oct 1; 6(10): 1257–64. Epub 2011 Oct 1. PMID: 21937883. PMCID: PMC3225843. DOI: 10.4161/epi.6.10.17728
- 27Kim M, Long TI, Arakawa K, Wang R, Yu MC, Laird PW. DNA methylation as a biomarker for cardiovascular disease risk. PLoS One. 2010 Mar 15. 5(3):
e9692 . PMID: 20300621; PMCID: PMC2837739. DOI: 10.1371/journal.pone.0009692 - 28Cuadrat RRC, Kratzer A, Arnal HG, Rathgeber AC, Wreczycka K, Blume A, et al. Cardiovascular disease biomarkers derived from circulating cell-free DNA methylation. NAR Genom Bioinform. 2023 Jun 28; 5(2):
lqad061 . PMID: 37388821. PMCID: PMC10304763. DOI: 10.1093/nargab/lqad061 - 29He Y, Chen X, Liu M, Zuo L, Zhai Z, Zhou L, et al. The potential DNA methylation markers of cardiovascular disease in patients with type 2 diabetes. BMC Med Genomics. 2023 Oct 12; 16(1): 242. PMID: 37828521. PMCID: PMC10568935. DOI: 10.1186/s12920-023-01689-3
- 30Armstrong NJ, Mather KA, Thalamuthu A, Wright MJ, Trollor JN, Ames D, et al. Aging, exceptional longevity and comparisons of the Hannum and Horvath epigenetic clocks. Epigenomics. 2017 May; 9(5): 689–700. Epub 2017 May 4. PMID: 28470125. DOI: 10.2217/epi-2016-0179
- 31Roberts JD, Vittinghoff E, Lu AT, Alonso A, Wang B, Sitlani CM, et al. Epigenetic age and the risk of incident atrial fibrillation. Circulation. 2021 Dec 14; 144(24): 1899–1911. Epub 2021 Sep 30. PMID: 34587750. PMCID: PMC8671333. DOI: 10.1161/CIRCULATIONAHA.121.056456
- 32Nacarelli T, Azar A, Potnis M, Johannes G, Mell J, Johnson FB, et al. The methyltransferase enzymes KMT2D, SETD1B, and ASH1 L are key mediators of both metabolic and epigenetic changes during cellular senescence. Mol Biol Cell. 2022 May 1; 33(5):
ar36 . Epub 2022 Feb 23. PMID: 35196069. PMCID: PMC9282020. DOI: 10.1091/mbc.E20-08-0523 - 33Grzeczka A, Graczyk S, Kordowitzki P. DNA methylation and telomeres—Their impact on the occurrence of atrial fibrillation during cardiac aging. Int J Mol Sci. 2023 Oct 28. 24(21):
15699 . PMID: 37958686; PMCID: PMC10650750. DOI: 10.3390/ijms242115699 - 34Hoff K, Lemme M, Kahlert AK, Runde K, Audain E, Schuster D, et al. DNA methylation profiling allows for characterization of atrial and ventricular cardiac tissues and hiPSC-CMs. Clin Epigenetics. 2019 Jun 11; 11(1): 89. PMID: 31186048. PMCID: PMC6560887. DOI: 10.1186/s13148-019-0679-0
- 35Hall AW, Chaffin M, Roselli C, Lin H, Lubitz SA, Bianchi V, et al. Epigenetic analyses of human left atrial tissue identifies gene networks underlying atrial fibrillation. Circ Genom Precis Med. 2020 Dec; 13(6):
e003085 . Epub 2020 Nov 6. PMID: 33155827. PMCID: PMC8240092. DOI: 10.1161/CIRCGEN.120.003085 - 36Tao H, Song ZY, Ding XS, Yang JJ, Shi KH, Li J. Epigenetic signatures in cardiac fibrosis, special emphasis on DNA methylation and histone modification. Heart Fail Rev. 2018 Sep; 23(5): 789–799. PMID: 29607455. DOI: 10.1007/s10741-018-9694-z
- 37Sohns C, Marrouche NF. Atrial fibrillation and cardiac fibrosis. Eur Heart J. 2020 Mar 7; 41(10): 1123–1131. PMID: 31713590. DOI: 10.1093/eurheartj/ehz786
- 38Reese-Petersen AL, Olesen MS, Karsdal MA, Svendsen JH, Genovese F. Atrial fibrillation and cardiac fibrosis: A review on the potential of extracellular matrix proteins as biomarkers. Matrix Biol. 2020 Sep; 91–92: 188–203. Epub 2020 Mar 20. PMID: 32205152. DOI: 10.1016/j.matbio.2020.03.005
- 39Pepin ME, Drakos S, Ha CM, Tristani-Firouzi M, Selzman CH, Fang JC, et al. DNA methylation reprograms cardiac metabolic gene expression in end-stage human heart failure. Am J Physiol Heart Circ Physiol. 2019 Oct 1; 317(4): H674–H684. Epub 2019 Jul 12. PMID: 31298559. PMCID: PMC6843013. DOI: 10.1152/ajpheart.00016.2019
- 40Bain CR, Ziemann M, Kaspi A, Khan AW, Taylor R, Trahair H, et al. DNA methylation patterns from peripheral blood separate coronary artery disease patients with and without heart failure. ESC Heart Fail. 2020 Oct; 7(5): 2468–2478. Epub 2020 Jul 2. PMID: 32618141. PMCID: PMC7524212. DOI: 10.1002/ehf2.12810
- 41Robinson EL, Ameri P, Delrue L, Vanderheyden M, Bartunek J, Altieri P, et al. Differential expression of epigenetic modifiers in early and late cardiotoxic heart failure reveals DNA methylation as a key regulator of cardiotoxicity. Front Cardiovasc Med. 2023 Mar 9; 10:
884174 . PMID: 36970338. PMCID: PMC10034031. DOI: 10.3389/fcvm.2023.884174 - 42Gibb AA, Hill BG. Metabolic coordination of physiological and pathological cardiac remodeling. Circ Res. 2018 Jun 22. 123(1): 107–128. PMID: 29929976; PMCID: PMC6023588. DOI: 10.1161/CIRCRESAHA.118.312017
- 43Kologrivova I, Shtatolkina M, Suslova T, Ryabov V. Cells of the immune system in cardiac remodeling: Main players in resolution of inflammation and repair after myocardial infarction. Front Immunol. 2021 Apr 2. 12:
664457 . PMID: 33868315; PMCID: PMC8050340. DOI: 10.3389/fimmu.2021.664457
